|
|
Article: Sankyo Signs as Subscriber to Nuclear Receptor Module of LifeSpan BioScience's DrugTarget Database; Agreement Is Sankyo's Second Subscription.
- Article from:
- Business Wire
- Article date:
- July 23, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
BIOWIRE2K
SEATTLE--(BW HealthWire)--July 23, 2002
LifeSpan BioSciences, Inc., a world leader in the emerging fields of molecular pathology and tissue proteomics, today announced that Sankyo Co., Ltd. of Tokyo, Japan has subscribed to the nuclear receptor (NR) module of LifeSpan's comprehensive DrugTarget Database. The NR module gives subscribers access to information on all major nuclear receptors for use in identifying and validating new gene targets for drug discovery. It is one of eight modules in LifeSpan's DrugTarget Database, which includes information on the gene families of greatest interest for ...